Access Vascular is a medical device company that develops novel bulk hydrophilic-based devices to improve venous access.
Access Vascular has raised $22.0M in total funding. The most recent round was Series C. The last funding was announced in October 2023.
Access Vascular's investors include TVM Capital Life Science, AngelMD, MedTech Innovator.
Access Vascular is headquartered in Bedford, United States.
Access Vascular is a medical device company that develops novel bulk hydrophilic-based devices to improve venous access.
Access Vascular is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Access Vascular — Funding & Investors." VCBacked, October 31, 2023, https://www.vcbacked.co/company/access-vascular. Accessed August 13, 2026.
VCBacked. (2023). Access Vascular — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/access-vascular
{{cite web |title=Access Vascular — Funding & Investors |url=https://www.vcbacked.co/company/access-vascular |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated